Literature DB >> 23902921

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria.

Bohdan Nosyk1, Bertrand Audoin, Chris Beyrer, Pedro Cahn, Reuben Granich, Diane Havlir, Elly Katabira, Joep Lange, Viviane D Lima, Thomas Patterson, Steffanie A Strathdee, Brian Williams, Julio Montaner.   

Abstract

In recent years, evidence has accumulated regarding the ability of HAART to prevent HIV transmission. Early supportive evidence was derived from observational, ecological and population-based studies. More recently, a randomized clinical trial showed that immediate use of HAART led to a 96% decrease in HIV transmission events within HIV serodiscordant heterosexual couples. However, the generalizability of the effect of HAART, and the population-level impact on HIV transmission continues to generate substantial debate. We, therefore, conducted a review of the evidence regarding the preventive effect of HAART on HIV transmission within the context of the Bradford Hill criteria for causality. Taken together, we find the accumulated evidence supporting HIV treatment as prevention meets each of the Bradford Hill criteria for causality. We conclude that the opportunity cost of inaction while waiting for additional evidence on the generalizability of effect in other risk groups is too high. Efforts should be redoubled to mobilize the financial capital and political will to optimize implementation of HIV Treatment as Prevention strategies on a wide scale.

Entities:  

Mesh:

Year:  2013        PMID: 23902921      PMCID: PMC4539010          DOI: 10.1097/QAD.0b013e32835f1d68

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  60 in total

1.  HIV treatment as prevention: to be or not to be?

Authors:  Myron S Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

2.  Use of the community viral load as a population-based biomarker of HIV burden.

Authors:  Amanda D Castel; Montina Befus; Sarah Willis; Angelique Griffin; Tiffany West; Shannon Hader; Alan E Greenberg
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

3.  Implications of the Henan Province report on the treatment as prevention debate.

Authors:  Julio Montaner; Robert Hogg
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

4.  HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention.

Authors:  Christian Anders Wathne Bruhn; Marcus Thomas Pius Gilbert
Journal:  Lancet Infect Dis       Date:  2011-04       Impact factor: 25.071

5.  Decline in deaths from AIDS due to new antiretrovirals.

Authors:  R S Hogg; M V O'Shaughnessy; N Gataric; B Yip; K Craib; M T Schechter; J S Montaner
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

Review 6.  Tuberculosis.

Authors:  Stephen D Lawn; Alimuddin I Zumla
Journal:  Lancet       Date:  2011-03-21       Impact factor: 79.321

Review 7.  Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.

Authors:  Jorge F Senise; Adauto Castelo; Marisol Martínez
Journal:  AIDS Rev       Date:  2011 Oct-Dec       Impact factor: 2.500

8.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

9.  HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.

Authors:  Gesine Meyer-Rath; Mead Over
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

Review 10.  HIV infection of the male genital tract--consequences for sexual transmission and reproduction.

Authors:  A Le Tortorec; N Dejucq-Rainsford
Journal:  Int J Androl       Date:  2009-06-15
View more
  11 in total

1.  HIV testing behaviors and attitudes among community recruited methamphetamine users in a South African township.

Authors:  Christina S Meade; Sheri L Towe; Melissa H Watt; Andrea L Hobkirk; Donald Skinner; Bronwyn Myers; Stephen M Kimani; Desiree Pieterse
Journal:  AIDS Behav       Date:  2015-01

Review 2.  Cost-effectiveness analysis along the continuum of HIV care: how can we optimize the effect of HIV treatment as prevention programs?

Authors:  B Nosyk; E Krebs; O Eyawo; J E Min; R Barrios; J S G Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

3.  Costs of health resource utilization among HIV-positive individuals in British Columbia, Canada: results from a population-level study.

Authors:  Bohdan Nosyk; Viviane Lima; Guillaume Colley; Benita Yip; Robert S Hogg; Julio S G Montaner
Journal:  Pharmacoeconomics       Date:  2015-03       Impact factor: 4.981

Review 4.  The HIV epidemic in Southern Africa - Is an AIDS-free generation possible?

Authors:  Wim Delva; Quarraisha Abdool Karim
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

Review 5.  Treatment as prevention--where next?

Authors:  Mark Hull; Joep Lange; Julio S G Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

6.  The causal effect of opioid substitution treatment on HAART medication refill adherence.

Authors:  Bohdan Nosyk; Jeong E Min; Guillaume Colley; Viviane D Lima; Benita Yip; M-J S Milloy; Evan Wood; Julio S G Montaner
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

Review 7.  Gonadal function and reproductive health in women with human immunodeficiency virus infection.

Authors:  Swaytha Yalamanchi; Adrian Dobs; Ruth M Greenblatt
Journal:  Endocrinol Metab Clin North Am       Date:  2014-09       Impact factor: 4.741

8.  Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England.

Authors:  Douglas S Krakower; Catherine E Oldenburg; Jennifer A Mitty; Ira B Wilson; Ann E Kurth; Kevin M Maloney; Donna Gallagher; Kenneth H Mayer
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

9.  How can we get close to zero? The potential contribution of biomedical prevention and the investment framework towards an effective response to HIV.

Authors:  John Stover; Timothy B Hallett; Zunyou Wu; Mitchell Warren; Chaitra Gopalappa; Carel Pretorius; Peter D Ghys; Julio Montaner; Bernhard Schwartländer
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

10.  Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.

Authors:  Xiao Zang; Houlin Tang; Jeong Eun Min; Diane Gu; Julio S G Montaner; Zunyou Wu; Bohdan Nosyk
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.